Hengrui has established multiple R&D centers and clinical centers in the United States, Japan, and China. These centers operate in a concert and together lay a solid foundation for innovative drug discovery and development.

U.S. R&D Center
Clinical Research, Business Development,and Regulatory Affairs with FDA
Japan R&D Center
Registration, Sales, and Distribution of Advanced Formulations
Shanghai R&D Center
Discovery of Lead Compounds and other Upstream Activities
Shanghai Clinical Center
Clinical Development and Registration
Lianyungang R&D Center
Manufacturing Process Development for Innovative and Generic Drugs; International Registration Research
Chengdu R&D Center
R&D of High Activity Compound, Hormones, and Contrast Agents
Nanjing R&D Center
Downstream of Shanghai R&D Center, API & Formulation Development